Tazarotene 0.045% Lotion for Acne: Formulation, Application Characteristics, and Clinical Efficacy and Safety

Main Article Content

Zoe Draelos
Emil Tanghetti
Linda Stein Gold
Hilary Baldwin
Leon Kircik
Eric Guenin

Keywords

tazarotene, acne, efficacy, safety

Abstract

N/A

References

1. Tanghetti EA, et al. J Dermatol Treat. 2019:1–8.

2. Tanghetti EA, et al. J Drugs Dermatol. 2019;18(6):542–548.

3. Chandraratna RAS. J Amer Acad Dermatol. 1997;18(6): 542–548.

4. Finzl E, et al. Am J Pathol. 1992;140(6):1463–1471.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 > >>